NAMPT and cancer: NAMPT inhibitors are being used in clinical trials as anti-cancer agents [24]–[27] and nicotinamidases are attractive targets to the development of drugs for infectious diseases and anti-parasitic therapies [7], [8], [22], [28]–[30].